Table 2. Subfoveal choroidal thickness and choroidal thickness at 4 cardinal macular locations in the left eye.
All 5 locations showed significantly decreased CTh in patients with coronary artery disease compared with controls.
| CAD (N = 34) | Control (N = 28) | |||||||
|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Min/Max | Mean (SD) | Min/Max | Mean CTh Difference | 95% CI | P-value | P-value adjusted* | |
| SF CTh (μm) | 252 (58.8) | 124/341 | 303 (63.2) | 139/416 | 50.2 | 19.2, 81.3 | P = 0.002 | P = 0.006 |
| N CTh (μm) | 198 (62.8) | 48.5/ 314 | 245 (65.3) | 86.0/369 | 46.4 | 14.5, 80.6 | P = 0.006 | P = 0.04 |
| T CTh (μm) | 218 (43.0) | 134/329 | 264 (47.8) | 134/342 | 46.2 | 22.3, 70.2 | P<0.001 | P = 0.003 |
| S CTh (μm) | 261 (66.6) | 117/357 | 320 (55.7) | 172/414 | 59.7 | 26.9, 92.5 | P<0.001 | P = 0.003 |
| I CTh (μm) | 234 (73.1) | 106/370 | 309 (63.6) | 171/437 | 74.5 | 38.5, 110.6 | P = 0.007 | P = 0.005 |
* Adjusted for diabetes, hypertension, and hypercholesterolemia.
CAD, coronary artery disease; SD, standard deviation; CI: confidence interval; CTh, choroidal thickness; SF, subfoveal; N, nasal; T, temporal; S, superior; I, inferior.